0000950123-21-015022.txt : 20211115
0000950123-21-015022.hdr.sgml : 20211115
20211112181900
ACCESSION NUMBER: 0000950123-21-015022
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210930
FILED AS OF DATE: 20211115
DATE AS OF CHANGE: 20211112
EFFECTIVENESS DATE: 20211115
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioImpact Capital LLC
CENTRAL INDEX KEY: 0001687078
IRS NUMBER: 364818254
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20107
FILM NUMBER: 211405411
BUSINESS ADDRESS:
STREET 1: 450 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 6174259200
MAIL ADDRESS:
STREET 1: 450 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: MPM Oncology Impact Management LP
DATE OF NAME CHANGE: 20161007
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001687078
XXXXXXXX
09-30-2021
09-30-2021
false
BioImpact Capital LLC
450 KENDALL STREET
CAMBRIDGE
MA
02142
13F HOLDINGS REPORT
028-20107
Y
The securities reported herein include securities previously included in the Form 13F filings of Burrage Capital Management LLC (File No. 028-20040), as Bioimpact Capital LLC acquired the assets of Burrage Capital Management LLC after June 30, 2021.
Ansbert Gadicke
Member
(617) 425-9200
/s/Ansbert Gadicke
Cambridge
MA
11-12-2021
0
33
644675
false
INFORMATION TABLE
2
7530.xml
INFORMATION TABLE FOR FORM 13F
ADC Therapeutics, Inc.
Common
H0036K147
9357
344519
SH
SOLE
344519
0
0
Amicus Therapeutics Inc.
Common
03152W109
5220
546558
SH
SOLE
546558
0
0
Avadel Pharmaceuticals Plc
Common
05337M104
3920
400000
SH
SOLE
400000
0
0
AVROBIO, Inc.
Common
05455M100
4809
861858
SH
SOLE
861858
0
0
Axsome Therapeutics Inc.
Common
05464T104
3631
110155
SH
SOLE
110155
0
0
Biocryst Pharmaceuticals Inc.
Common
09058V103
10128
704767
SH
SOLE
704767
0
0
Black Diamond Therapeutics, Inc.
Common
09203E105
2102
248506
SH
SOLE
248506
0
0
Crinetics Pharmaceuticals Inc.
Common
22663K107
6281
298392
SH
SOLE
298392
0
0
Cullinan Oncology, Inc.
Common
230031106
172621
7648268
SH
SOLE
7648268
0
0
Cytokinetics Inc.
Common
23282W605
8838
247291
SH
SOLE
247291
0
0
Epizyme, Inc.
Common
29428V104
20341
3972830
SH
SOLE
3972830
0
0
ESSA Pharma, Inc.
Common
29668H708
5466
683287
SH
SOLE
683287
0
0
G1 Therapeutics, Inc.
Common
3621LQ109
11548
860502
SH
SOLE
860502
0
0
Geron Corporation
Common
374163103
7854
5732770
SH
SOLE
5732770
0
0
Harmony Biosciences Hldgs Inc.
Common
413197104
5813
151650
SH
SOLE
151650
0
0
Harpoon Therapeutics, Inc.
Common
41358P106
25254
3196707
SH
SOLE
3196707
0
0
Inozyme Pharma Inc.
Common
45790W108
3717
320724
SH
SOLE
320724
0
0
Intellia Therapeutics, Inc.
Common
45826J105
21815
162620
SH
SOLE
162620
0
0
iTeos Therapeutics, Inc.
Common
46565G104
56891
2107092
SH
SOLE
2107092
0
0
Lucira Health Inc.
Common
54948U105
4394
578114
SH
SOLE
578114
0
0
MEI Pharma, Inc.
Common
552798202
34484
12494118
SH
SOLE
12494118
0
0
Merus N.V.
Common
N5749R100
20723
941948
SH
SOLE
941948
0
0
Mirum Pharmaceuticals Inc.
Common
604749101
6146
308532
SH
SOLE
308532
0
0
Neogenomics Inc.
Common
64049M209
7212
149504
SH
SOLE
149504
0
0
Oncorus, Inc.
Common
68236R103
22201
2377031
SH
SOLE
2377031
0
0
Repare Therapeutics, Inc.
Common
760273102
43030
1639849
SH
SOLE
1639849
0
0
Revolution Medicines, Inc.
Common
76155X100
4127
150000
SH
SOLE
150000
0
0
TCR2 Therapeutics, Inc.
Common
87808K106
28687
3370982
SH
SOLE
3370982
0
0
Travere Therapeutics Inc.
Common
89422G107
7433
306515
SH
SOLE
306515
0
0
Turning Point Therapeutics, Inc.
Common
90041T108
18026
271350
SH
SOLE
271350
0
0
Verastem, Inc.
Common
92337C104
8701
2824857
SH
SOLE
2824857
0
0
Werewolf Therapeutics, Inc.
Common
95075A107
40978
2388011
SH
SOLE
2388011
0
0
YmAbs Therapeutics, Inc.
Common
984241109
12928
452970
SH
SOLE
452970
0
0